Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
SEARCH JOURNAL     advanced search
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 292, 156 - 158 (09 July 1981); doi:10.1038/292156a0

Stage-specific embryonic antigen involves alphalright arrow 3 fucosylated type 2 blood group chains

H. C. Gooi*, T. Feizi*, A. Kapadia*, B. B. Knowles, D. Solter & M. J. Evans

*Clinical Research Centre, Watford Road, Harrow, Middlesex HA1 3UJ, UK
Wistar Institute of Anatomy, Philadelphia, Pennsylvania 19104, USA
Department of Genetics, University of Cambridge, Cambridge CBQ 3EH, UK

There is much interest in developmentally regulated molecules which may have function in cell interactions and sorting during embryogenesis and differentiation. Numerous antisera have been raised which detect antigens that are expressed in early embryonic cells and become restricted during differentiation, being expressed in only a minority of adult cells (reviewed in refs 1−3). The precise antigenic determinants recognized by such antisera have not been defined. However, studies using a hybri-doma antibody against mouse spleen cells4 and monoclonal autoantibodies of patients with cold agglutinin disease5 have shown that two defined carbohydrate antigen systems, the Forssman and the li antigens, have stage-specific expression in early mouse embryos. We now describe evidence that the stage-specific embryonic antigen SSEA-1 (ref. 6) involves the carbohydrate sequence Galbeta1 right arrow 4GlcNAc up arrow1,3 Fucalpha This determinant is formed by alpha 1 right arrow 3 fucosylation of blood group I or i antigens which are branched or linear oligosaccharides, respectively7−9, built of Galbeta1 right arrow4GlcNAc units and known as type 2 precursor chains10 of the major blood group antigens. Thus, we introduce the concept of simple glycosylation changes as a basis for stage-specific expression of embryonic antigens.

------------------

References
1. Jacob, F. Curr. Topics dev. Biol. 13, 117−137 (1979).
2. Solter, D. & Knowles, B. B. Curr. Topics dev. Biol 13, 139−165 (1979).
3. Wiley, L. M. Curr. Topics dev. Biol. 13, 167−193 (1979).
4. Willison, K. R. & Stern, P. L. Cell. 14, 785−793 (1978).
5. Kapadia, A., Feizi, T. & Evans, M. J. Expl Cell Res. 131, 185−195 (1981).
6. Solter, D. & Knowles, B. B. Proc. natn. Acad. Sci. U.S.A. 75, 5565−5569 (1978).
7. Watanabe, K., Hakomori, S., Childs, R. A. & Feizi, T. J. boil. Chem. 254, 3221−3228 (1979).
8. Feizi, T., Childs, R. A., Watanabe, K. & Hakomori, S. J. exp. Med. 149, 975−980 (1979).
9. Niemann, H. et al. Biochem. biophys. Res. Commun. 81, 1286−1293 (1978).
10. Watkins, W. M. Adv. Hum. Genet. 10, 1−136, 379−385 (1980).
11. Fox, N. et al. Devl BioL (in the press).
12. Nudelman, E. et al. Biochim. biophys. Res. Commun. 97, 443−451 (1980).
13. Wood, E., Lecomte, J., Childs, R. A. & Feizi, T. Molec. Immun. 16, 813−819 (1979).
14. Lloyd, K. O., Kabat, E. A. & Licerio, E. Biochemistry 7, 2976−2990 (1968).
15. Watkins, W. M. & Morgan, W. T. J. Vox Sang. 4, 97−119 (1959).
16. Schiffman, G., Kabat, E. A. & Thompson, W. Biochemistry 3, 113−120 (1964).
17. Wood, E., Hounsell, E. F., Langhorne, J. & Feizi, T. Biochem. J. 187, 711−718 (1980).
18. Feizi, T. et al. J. exp. Med. 133, 39−52 (1971).
19. Koscielak, J. in Human Blood Groups (eds Mohn, J. F. et al. 143−149 (Karger, Basle, 1977).
20. Muramatsu, T. et al. Cell 18, 183−191 (1979).
21. Augé, C., David, S. & Veyrières, A. Nouv. J. Chim. 3, 491−497 (1979).
22. Feizi, T., Wood, E., Augé, S. & Veyrieres, A. Immunochemistry 15, 733−736 (1978).
23. Wood, E. & Feizi, T. FEBS Lett. 104, 135−140 (1979).
24. Kobata, A. Meth. Enzym. 28, 262−271 (1972).
25. Feizi, T. Revue fr. Transfusion Immuno-hemat. 23, 563−577 (1980).
26. Yang, H.-J. & Hakomari, S. J. biol. Chem. 246, 1192−1200 (1971).
27. Feizi, T., Kapadia, A., Gooi, H. C. & Evans, M. J. in Teratocarcinoma and Cell Surface (eds Muramatsu, T. & Ikawa, Y.) (Japan Scientific Societies Press, Tokyo, in the press).
28. Feizi, T. et al. J. Immun. 106, 1578−1592 (1971).
29. Szulman, A. E. in Human Blood Groups (eds Mohn, J. P. et al. 426−436 (Karger, Basle, (1977).
30. Prieels, J.-P. et al. Proc. natn. Acad. Sci. U.S.A. 75, 2215−2219 (1978).
31. Ziomek, C. A. & Johnston, M. H. Cell 21, 935−942, 1980.
32. Oppenheimer, S. B. Expl Cell Res. 92, 122−126 (1975).
33. Grabel, L. B., Rosen, S. D. & Martin, G. R. Cell 17, 477−484 (1979).
34. Neufeld, E. & Ashwell, G. in The Biochemistry of Glycoproteins and Proteoglycans (ed. Lennarz, W. J.) 241−266 (Plenum, New York, 1980).
35. Day, J. F., Thornburg, R. W., Thorpe, S. R. & Baynes, J. W. J. biol. Chem. 255, 2360−2365 (1980).
36. Stahl, P. et al. Cell 19, 207−215 (1980).



© 1981 Nature Publishing Group
Privacy Policy